Skip to main content
OpenTrials

Clinical trial condition

Fibrolamellar Carcinoma

Explore clinical trials studying Fibrolamellar Carcinoma. Study availability and eligibility vary by location and protocol.

9 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Fibrolamellar Carcinoma trial results

Recruiting

Agnostic Therapy in Rare Solid Tumors

NCT06638931

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adenoma, +131 more
Locations
  • Hospital São Carlos Fortaleza, Ceará, Brazil
  • Hospital São Rafael Salvador, Estado de Bahia, Brazil
  • Hospital Santa Cruz Curitiba, Paraná, Brazil
  • IDOR Recife Recife, Pernambuco, Brazil
View Trial Details
Recruiting

Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma

NCT04134559

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Children's Hospital Boston Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Cincinnati Children's Medical Center Cincinnati, Ohio, United States
View Trial Details
Completed

Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)

NCT01642186

Conditions
Fibrolamellar Carcinoma, Fibrolamellar Liver Cancer, Fibrolamellar hepatocellular carcinoma
Locations
  • University of California San Francisco San Francisco, California, United States
  • John Hopkins Medical Center Baltimore, Maryland, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery

NCT03533582

Conditions
Childhood Hepatocellular Carcinoma, Childhood Malignant Liver Neoplasm, Fibrolamellar Carcinoma, +6 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 205 locations
View Trial Details
Active, Not Recruiting

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

NCT03860272

Conditions
Adnexal Diseases, Advanced Cancer, Angiosarcoma, +42 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • The Angeles Clinic & Research Institute, a Cedars-Sinai Affiliate Los Angeles, California, United States
  • University of Southern California Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

NCT06521567

Conditions
Adenocarcinoma, Astrocytoma, Brain Diseases, +56 more
Locations
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Iowa City, Iowa, United States
  • GSK Investigational Site Hackensack, New Jersey, United States
  • GSK Investigational Site Cincinnati, Ohio, United States
View all 20 locations
View Trial Details

Related conditions